Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.
Kubota M, Zhang BS, Li SY, Yoshida Y, Wang H, Adachi A, Matsutani T, Mine S, Machida T, Kamitsukasa I, et al. Med Int (Lond). 2023 Jan-Feb; 3(1):4. Epub 2022 Dec 21.